Application of pharmacoeconomics in the field of medical insurance

What is the application of pharmacoeconomics in the field of medical insurance?

The application of pharmacoeconomics in the field of medical insurance is mainly reflected in the following aspects:

Cost-benefit analysis of drugs: By comparing the costs and effects of different drug treatment schemes, the most economical and effective treatment scheme is determined. This helps medical insurance institutions to provide patients with the best medical security within a limited budget.

Pharmacoeconomic evaluation: to determine the value of specific drugs or treatments in the medical insurance system through economic evaluation. This helps medical insurance institutions to decide whether to include the drug or treatment in the medical insurance catalogue and determine the payment price.

Drug price negotiation: through pharmacoeconomic evaluation, medical insurance institutions can negotiate with drug manufacturers to reduce drug prices and improve the efficiency of medical insurance funds.

Optimal allocation of drug resources: according to the medical needs and resource conditions in different regions, through pharmacoeconomic analysis, optimize the procurement, distribution and use of drugs to ensure the rational allocation of drug resources.

To sum up:

The application of pharmacoeconomics in the field of medical insurance is helpful to improve the level of medical security, reduce medical expenses and optimize the allocation of resources. Through the cost-benefit analysis of different drug treatment schemes, pharmacoeconomic evaluation, drug price negotiation and optimal allocation of drug resources, medical insurance institutions can manage and use medical insurance funds more effectively and provide patients with more economical and effective medical services.

Legal basis:

The Social Insurance Law of People's Republic of China (PRC) stipulates that the state shall establish and improve the basic medical insurance system for urban residents to ensure the basic medical needs of urban and rural residents. At the same time, the law also stipulates the principles of the use and management of medical insurance funds, including the supervision and negotiation mechanism of drug prices. In addition, the Drug Administration Law of People's Republic of China (PRC) also stipulates the management and supervision mechanism of drug prices to ensure the rationality and fairness of drug prices.